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ABSTRACT: Fixed-bed column processes using the anionic resin Q Sepharose XL were evaluated for cephamycin C (CepC)
puriﬁcation from fermentation broth. Breakthrough and desorption curves were obtained for diﬀerent ﬂow rates (2.5, 5.0, and 7.5
mL/min). The elution method consisted of a stepwise gradient using NaCl solutions (0.1%, 0.3%, and 0.5%), which resulted in
the separation of CepC from other antibiotics. The ﬂow rate did not interfere in adsorption during loading of the column, but
band broadening was observed during elution as the ﬂow rate was increased. After the ion-exchange process, the fractions
containing CepC were subjected to solid-phase extraction using a C18 cartridge to remove salts. Analyses of the broth used to
feed the column and of the salt-free fractions by LC−MS showed a reduction in the concentration of some contaminants
(possibly penicillin N, deacetylcephalosporin C, and deacetoxycephalosporin C) compared to the concentration of CepC. In
conclusion, ion exchange followed by adsorption on a C18 adsorbent was demonstrated to be a selective and eﬃcient procedure
for the puriﬁcation of CepC from fermentation broth.
1. INTRODUCTION
Cephamycin C (CepC) is an important β-lactam compound
belonging to the class of cephalosporins. As a β-lactam
antibiotic, it aﬀects peptidoglycan synthesis in prokaryotes,
aﬀecting cell-wall integrity.1 In the cephalosporin group, CepC
is more active against Gram-negative and anaerobic bacteria
than the other cephalosporins, and it is also more resistant to
some types of β-lactamase enzymes.2 These enzymes are
produced by some pathogenic bacteria and represent one of the
most important mechanisms of bacterial resistance to β-lactam
antibiotics.3
CepC is usually produced by submerged fermentation with
Streptomyces clavuligerus and Nocardia lactamdurans.4 To obtain
this antibiotic at an adequate purity level, the use of appropriate
downstream techniques is essential to isolate it from the
fermentation broth. Separation techniques based on adsorption
and ion-exchange processes have been widely applied for the
isolation and puriﬁcation of products obtained during
bioprocesses.5−10 These processes stand out from other
separation techniques because they provide a high concen-
tration factor, which satisﬁes the need for a high recovery of the
product of interest.11 Moreover, they are nondenaturing, highly
selective, and relatively inexpensive processes.12 For biophar-
maceuticals, ion exchange and adsorption are mainly carried out
by packed-bed chromatography. The prevalence of this unit
operation is mainly due to the high-resolution separations
obtained even for similar compounds. Advances in resin
chemistry and synthesis have improved resin selectivity and
mechanical resistance, making these materials adequate to
satisfy industrial demands for high purity and throughput.13,14
Ion exchange can be considered as an interesting technique
for the extraction and puriﬁcation of CepC from fermentation
broths, because of the amphoteric nature of this molecule.
CepC presents amino and carboxylic groups, which, depending
on pH, are ionized and can bind to the active sites of the resin
by displacing other previously bonded ions.
Although the discovery of CepC was announced between
1971 and 1972, by researchers from the Lilly and Merck
laboratories,3 literature data about processes for CepC
puriﬁcation are scarce. Most of the available information has
been reported in patents, and the most recent patent was
published more than 30 years ago, in 1982.15−19 In the
processes claimed by these patents, operations of ﬁltration, ion
exchange on polymeric resins, and adsorption on activated
carbon or on neutral polymeric resins were employed. Among
these patents, that of Kawamura and co-workers claimed a
process to obtain the sodium salt of CepC, and in addition to
the unit operations already mentioned, the authors also used
size-exclusion chromatography, precipitation with acetone, and
thin-layer chromatography.16 After the patent granted to
Kamogashira et al.,15 only the recent study by Baptista-Neto
et al. on the puriﬁcation of CepC from fermentation broth can
Received: November 14, 2014
Revised: March 3, 2015
Accepted: March 3, 2015
Published: March 3, 2015
Article
pubs.acs.org/IECR
© 2015 American Chemical Society 3018 DOI: 10.1021/ie504499z
Ind. Eng. Chem. Res. 2015, 54, 3018−3026
be found in the literature.5 These authors evaluated the
adsorption of CepC in ﬁxed-bed columns using the anionic
resin Q Sepharose XL and the neutral resin XAD1180. The
results showed that CepC was able to adsorb onto the anionic
resin, but that the antibiotic was weakly bound to the neutral
resin, being eluted during the column washing step. This study
did not show separation of diﬀerent compounds during elution
for any of the resins evaluated.
One of the greatest diﬃculties hindering the study of CepC
production and puriﬁcation is the absence of a standard
compound.4 As CepC is not directly used as an antibiotic, a
standard for this compound is not commercially available.
Puriﬁcation studies of this antibiotic are of great signiﬁcance,
because they can provide useful information on achieving the
pure form of CepC. Therefore, in this study, the separation and
puriﬁcation of CepC from fermentation broth was evaluated
using the ion-exchange technique in ﬁxed-bed column
processes. The resin Q Sepharose XL was used because of its
good adsorption capacities, as already reported in the
literature.5 We investigated the inﬂuence of diﬀerent ﬂow
rates on the column performance by obtaining breakthrough
and desorption curves. To obtain a puriﬁed fraction of CepC,
an elution method was proposed, and the separation of CepC
from contaminants was evaluated. As chemical standards for
CepC and the main contaminants were not available, an
alternative method for qualitatively evaluating the separation of
CepC from contaminants was to use mass spectrometric
analysis, which is a technique that is sensitive enough to detect
compounds present in very low quantities according to their
molecular weight. In this analysis, all of the ionizable
compounds present in a sample are detected. Therefore, the
signal intensities of the ions generated by the molecules of
CepC and contaminants could be compared, and the
puriﬁcation achieved could be evaluated.
2. EXPERIMENTAL SECTION
2.1. Resins. The neutral resin Amberlite XAD4 was
purchased from Sigma (Lyon, France). According to the
manufacturer’s speciﬁcations, this resin has the following
characteristics: styrene/divinylbenzene matrix, mean pore size
of 100 Å, pore volume of approximately 0.98 mL/g; surface
area of 750 m2/g, and particle size of 20−60 mesh (0.25−0.85
mm). Before use in the experiments, XAD4 was sequentially
treated with 50% methanol, deionized water, 50% ethanol, and
deionized water, in an agitated tank.
The anionic resin Q Sepharose XL (QXL) was purchased
from GE Healthcare (Stockholm, Sweden) and had the
following characteristics: matrix structure formed by cross-
linked 6% agarose with bound dextran, spherical beads with a
mean particle size of 90 μm, and ionic capacity of 0.18−0.25
mmol of Cl−/mL of adsorbent. The QXL pretreatment was
carried out in a column by sequentially passing through the bed
three bed volumes (BV) of 0.5 N NaOH + 1 M NaCl, 2 BV of
deionized water, 1 BV of 25% acetic acid, and ﬁnally, 4−5 BV of
deionized water.
2.2. Fermentation Broth and Pretreatment Condi-
tions. CepC was produced by Streptomyces clavuligerus (DSM
41826) under batch fermentation conditions, according to the
methodology described by Bellaõ et al.20 The fermentation
medium consisted essentially of soybean derivatives and lysine
as nitrogen sources and glycerol as a source of carbon and
energy.
Before the ion-exchange experiments, the fermentation broth
was subjected to three sequential treatments: microﬁltration,
ultraﬁltration, and adsorption on the resin Amberlite XAD4 for
pigment removal. Filtrations were carried out in hollow-ﬁber
cartridges (GE Healthcare, Wauwatosa, WI). Membranes with
a pore size of 0.22 μm and 3 kDa and ﬁltration areas of 3600
and 2800 cm2 were used for microﬁltration and ultraﬁltration,
respectively.
The adsorption process for pigment removal was carried out
by pouring the pretreated XAD4 resin and the ultraﬁltered
broth into a stirred tank, and the system was maintained under
agitation for 30 min at room temperature. Then, the resin was
separated from the clariﬁed broth, which was used in the ion-
exchange experiments. At the end, the pH of the clariﬁed broth
was between 6 and 6.5. This operation was necessary to avoid
loss of the QXL resin, as colored compounds can irreversibly
adsorb onto the resin.5
2.3. Fixed-Bed Experiments. As already mentioned, the
clariﬁed broth’s pH was between 6 and 6.5. The pKa of CepC is
2.5; therefore, the molecules were negatively charged during the
ion exchange. The adsorption onto and desorption from the
anionic resin involved an ion-exchange equilibrium according to
the following mechanism
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where resin+Clx
− represents the anionic resin in the Cl− form
and containing x actives sites; M− represents the negatively
charged molecules in the broth, which could be both CepC and
contaminants; and resin+Cl(x−z)
−Mz
− is the resin with z binding
sites occupied by M−. During column loading, the concen-
trations of species M− in the broth were high, and the reaction
shifted toward the right. During the elution step, however, the
concentration of Cl− was increased, shifting the system to the
left and releasing CepC− and other M− compounds.
The column experiments were planned to evaluate the
inﬂuence of the ﬂow rate on the breakthrough curves and the
column elution. A jacket glass column (GE Healthcare,
Stockholm, Sweden) with an internal diameter of 1 cm was
used, and the bed heights for the assays were 25.6 cm (CR1),
26.0 cm (CR2), and 25.6 cm (CR3). Three ﬂow rates were
tested, namely, 2.5 mL min−1 (CR1), 5.0 mL min−1 (CR2), and
7.5 mL min−1 (CR3), corresponding to the linear velocities 5.3,
10.6, and 15.9 m s−1, respectively.
The procedure used for the clariﬁed broth puriﬁcation
consisted of the following steps: (1) application of approx-
imately 50 mL of clariﬁed broth to the column; (2) bed
washing with 100 mL (∼5 BV) of deionized water to remove
unabsorbed molecules in the interstitial space; (3) elution using
a stepwise gradient of 400 mL (∼20BV) of 0.1% NaCl, 400 mL
of 0.3% NaCl, and 400 mL of 0.5% NaCl. Fractions of 3 mL
(during the feed step) and 20 mL (during the other steps) were
collected to determine the CepC concentration, the antimicro-
bial activity, and the presence of contaminants. These assays
were carried out at 20 °C.
During the elution of the column, fractions containing CepC
were collected, freeze-dried (FreeZone Freeze-Dry Systems,
LABCONCO, Kansas City, MO), and kept at −80 °C for
posterior analysis in a mass spectrometer. These analyses were
performed to detect ions corresponding to the molecules of
CepC and contaminants. The results were used to qualitatively
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evaluate the puriﬁcation obtained in the ion-exchange column
process.
2.3.1. Breakthrough Curves. The breakthrough curves were
determined by plotting the changes in the concentration of
CepC (expressed as C/C0) along the experiment, during the
feeding step and part of the washing step of the column. C and
C0 are the CepC concentrations in the column outlet and in the
feed, respectively. From these curves, some variables related to
the resin uptake capacity and bed utilization were calculated,
and the process eﬃciency was determined. The variables
calculated were the breakthrough time (tb), the amount of
CepC adsorbed per bed volume until column saturation (qt)
(eq 1), the column bed volume (BV) (eq 2), the bed utilization
(ϕ1) (eq 3) and product recovery (ϕ2) (eq 4) eﬃciencies, and
the productivity (P) (eq 5). The calculations were carried out















































































where C0 is the CepC concentration in the clariﬁed broth, C is
the CepC concentration at time t, Q is the ﬂow rate, BV is the
column bed volume, te is the time at which C/C0 = 1, and tb is
taken as the time at which C/C0 ≈ 0.1.
2.3.2. Desorption Analysis. The inﬂuence of ﬂow rate during
the desorption step was evaluated according to the van
Deemter equation, which relates the height equivalent to a
theoretical plate (HETP) and the linear velocity
μ
μ= + +A B CHETP
(6)
where u is the linear velocity and A−C are constants. The A
term represents the multipath eﬀect, the B term is linked to
axial diﬀusion, and the C term corresponds to mass transfer.23
HETP was calculated as previously described in the literature,
considering the peak of CepC obtained during the elution of
the column.24
2.4. CepC Recovery Calculation. Recoveries of CepC in










where C0 and V0 are the concentration of the solution feed and
the volume applied into the column, respectively; Ci and Vi are
the concentration and volume, respectively, of the fraction
collected at the column outlet, and i and N are the ﬁrst and last
fractions, respectively, collected in each step of column
operation. The calculations were carried out for each step of
the column operation (feed, washing and elution). The total
recovery consisted of the sum of the recoveries of all steps.
2.5. Solid-Phase Extraction. Solid-phase extraction was
carried out with the fractions containing CepC collected in the
ion-exchange column before their injection into the mass
spectrometer. This process was carried out to remove the salts
from the fractions, which could interfere in the ionization of the
molecules in the liquid chromatography−mass spectrometry
(LC−MS) system. A C18 SPE cartridge (10 g) (Waters,
Dublin, Ireland) was used in the solid-phase extraction. Before
sample application, the cartridge was treated by sequentially
passing 50 mL of methanol and 30 mL of deionized water
through it. After that, the freeze-dried fractions were
resuspended in 10 mL of citrate/phosphate buﬀer (pH 2.6)
and applied to the cartridge. The cartridge was then washed
with 30 mL of water to remove unbound molecules and eluted
with 50 mL of 50% methanol. Fractions of 4 mL were collected
for CepC concentration determinations and mass spectrometry
analyses. A low buﬀer pH was used to suppress the ionization
of CepC’s carboxylic group.
2.6. Analytical Methods. 2.6.1. CepC and Contaminant
Determinations. The concentration of CepC was determined
by high-performance liquid chromatography (HPLC) accord-
ing to the methodology described by Baptista-Neto et al.25 The
analysis was carried out using a 4-μm Synergi MAX RP 12
column (Phenomenex, Torrance, CA) at 28 °C and 0.01 M
acetic acid as the mobile phase at a ﬂow rate of 2 mL/min.
Peaks were detected at 254 nm. The HPLC system (Waters,
Milford, MA) used for the analyses consisted of two pumps, an
automatic injector, a temperature controller, and a photodiode
array (PDA) detector.
Contaminants were determined by UV absorbance at
wavelengths between 310 and 400 nm. Data were collected
on an Ultrospect 2100 spectrophotometer (GE Healthcare
Europe, Munich, Germany) and stored using Swift II data
acquisition software. This methodology detects in the sample
all of the compounds that absorb light at these wavelengths and
does not detect CepC, which does not absorb at wavelengths
above 310 nm.25 The contaminants were quantiﬁed in terms of
the area under the curve of wavelength versus absorbance.
2.6.2. Antimicrobial Activity. The antimicrobial activities of
the fractions collected during the ion-exchange experiments
were estimated according to the method described by Peŕez-
Redondo et al.,26 which is based on growth inhibition zones
formed in agar previously seeded with a test microorganism.
The solution to be tested was poured into wells made in the
agar plate, and after incubation, the inhibition zones were
measured. Escherichia coli (ESS), which is a bacterium sensitive
to CepC, was the microorganism used in these assays.
2.6.3. LC−MS Analyses. Liquid chromatography−mass
spectrometry (LC−MS) analyses were carried out using
Thermo Finnigan LXQ equipment (Waltham, MA) composed
of a pump, an autosampler, and a PDA detector coupled to a
mass spectrometer. A Hypersil Gold C18 column (100 × 4.6
mm) (Thermo Electron Corporation, Madison, WI) with a
particle size of 5 μm was used in the analyses. The mobile phase
consisted of methanol/water (70:30 v/v) with 0.1% acetic acid
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and was used at a ﬂow rate of 0.4 mL/min. The ion-trap mass
spectrometer was equipped with an electrospray ion (ESI)
source, and ionization was performed in positive mode. The
capillary temperature was set to 300 °C, and the voltages of the
source and capillary were 5 kV and 3 V, respectively. The
sheath, auxiliary, and sweep gas ﬂows used were 70, 30, and 30
units, respectively.
2.7. Chemicals. All chemicals used in this study were of
analytical grade, with the exception of acetic acid (Mallinckrodt,
Hazelwood, MO) and methanol (J.T. Baker, Ecatepec,
Mexico), which were of HPLC grade. NaCl was purchased
from QHEMIS (Jundiai,́ Brazil). Phosphate/citrate buﬀer was
prepared by dissolving appropriate masses of anhydrous citric
acid (QHEMIS, Jundiai,́ Brazil) and sodium phosphate dibasic
heptahydrate (Synth, Saõ Paulo, Brazil) in the fractions
collected by ion exchange.
3. RESULTS AND DISCUSSION
3.1. Ion-Exchange Column Processes on QXL Resin.
The experimental breakthrough curves exhibited similar proﬁles
(Figure 1). An unusual phenomenon was observed: During a
certain period of time, the CepC concentration in the column
outlet reached higher values than that in the feed (C > C0).
This behavior can be explained by a sequential ion-exchange
mechanism that occurs because of the competition of diﬀerent
ionic species for the adsorption sites.27 As a consequence, when
no more sites were available for adsorption, contaminants in the
bulk were able to displace the already adsorbed CepC, which
was released into the liquid phase. This might explain why,
during a certain period of time, there was more CepC in the
column eﬄuent than in the feed, and it also explains the
reduction in the concentrations of the contaminants after
column saturation. Competitive adsorption has also been
observed during the ion exchange of metals in zeolites, the
separation of α-lactalbumin from bovine serum albumin,28 the
removal of acetic acid and butanoic acid from industrial
condensate of a beet distillery,29 and the removal of nitrate
from groundwater.30
The eﬃciencies, productivities, and other process parameters
calculated from the breakthrough curves are summarized in
Table 1. As expected, the results showed that the process
operated at the highest ﬂow rate reached the breakthrough time
faster. Signiﬁcant diﬀerences were not observed for the
eﬃciencies (ϕ1 and ϕ2), indicating that the ﬂow rate did not
interfere with CepC adsorption. The high values obtained for
the product recovery eﬃciency (ϕ2) suggest a good aﬃnity
between CepC and the active sites of the resin. Additionally,
the values of bed utilization eﬃciency (ϕ1) were also high (92−
94%), showing that the resin bed was used to nearly its full
capacity. The best productivity value was obtained in the assay
using the highest ﬂow rate.
The desorption proﬁles for each assay are shown in Figure 2,
and Table 2 reports the HETP values obtained. A crescent
tendency in the HETP values with increasing linear velocity was
observed, which is the behavior predicted by the van Deemter
equation C term. This suggests that, for the range of ﬂow rates
evaluated, the mass transfer between the liquid bulk and the
resin was the main mechanism aﬀecting the eﬃciency of the
column. Considering this analysis, the lowest ﬂow rate was
more appropriate for the elution step. CepC was recovered in
0.1 L of 0.1% NaCl solution during assay CR1, whereas it was
recovered in volumes that were 20% and 40% larger during
assays CR2 and CR3, respectively.
The proposed elution method was able to separate CepC
from other antibiotics present in the broth, as two separate
fractions with antibacterial activity against E. coli were detected
(Figure 2). The ﬁrst peak was obtained by elution with 0.1%
NaCl solution, whereas the second peak was detected during
elution with 0.5% NaCl solution. HPLC analyses revealed that
Figure 1. Proﬁles of cephamycin C, contaminants, and antimicrobial
activity during feed application and part of the washing step in ﬁxed-
bed columns with Q Sepharose XL resin. CR1, 2.5 mL/min (5.3 m/s);
CR2, 5.0 mL/min (10.6 m/s); CR3, 7.5 mL/min (15.9 m/s). Values
are given in ﬂow rates (corresponding linear velocity).
Table 1. Parameters Calculated from Breakthrough Curves
in Fixed-Bed Columns Packed with Q Sepharose XL Resin
parametera CR1 CR2 CR3
tb (min) 13.60 6.40 4.53
qt (mg/mL) 0.17 0.16 0.19
ϕ1 0.94 0.92 0.92
ϕ2 0.99 0.99 0.99
P (mg/min) 0.36 0.71 1.16
atb, break-point time; qt, amount of CepC adsorbed per bed volume
until column saturation; ϕ1, eﬃciency of bed utilization; ϕ2, product
recovery eﬃciency; P, productivity.
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CepC was present only in the ﬁrst peak. The compounds
present in the second peak were not identiﬁed; however, they
might be intermediates of the biosynthetic pathway of CepC
that can also be produced in small quantities and secreted to
the culture medium and also have antibacterial activity.31
The contaminant proﬁles showed that some of these
compounds were released together with CepC, with the rest
being released during the elutions with 0.3% and 0.5% NaCl
solutions. Therefore, the proposed methodology was able to
separate CepC from some contaminants present in the feed,
but the fraction obtained was not yet in pure form.
The CepC recoveries after the ion-exchange processes are
reported in Table 3. The total recovery of CepC was high for all
of the processes evaluated, ranging near 90%. The increase in
the operating ﬂow rate showed a tendency to increase the
CepC recovery. The highest amount of CepC was recovered
during the feed and washing steps. This probably occurred
because the column was fed beyond bed saturation, as, at this
point of the study, the CepC breakthrough point was not
known. After obtaining the breakthrough curves, it was possible
to determine the time at which the loading of the column
should have stopped, called the breakthrough time (tb). In
practice, the column should be loaded until a small amount of
CepC is detected in the eﬄuent of the column (C/C0 < 0.1). In
this way, loss of CepC would be smaller in the initial steps, and
most of the antibiotic would be recovered during elution.
As the eﬃciencies were not aﬀected by the ﬂow rate, for the
feed step, a ﬂow rate of 7.5 mL/min was selected among the
tested operating conditions as being the most suitable to be
used in this process, because it promoted the best productivity
value. For the desorption step, the ﬂow rate of 2.5 mL/min was
the best, as it resulted in the lowest value of HETP obtained.
Baptista-Neto et al.5 proposed a process for CepC
puriﬁcation using the same resin (Q Sepharose XL) as used
in the present study. However, the ﬁxed-bed experiments that
they proposed using QXL resin were not able to separate
diﬀerent peaks, and only one large fraction containing CepC in
a mixture with other compounds was obtained during the
elution step.
Figure 2. Adsorption and elution proﬁles of cephamycin C,
compounds with antibacterial activity and contaminants in ﬁxed-bed
columns with Q Sepharose XL resin at three ﬂow rates (corresponding
linear velocities): (A) 2.5 mL/min (5.3 m/s), (B) 5.0 mL/min (10.6
m/s), (C) 7.5 mL/min (15.9 m/s).
Table 2. HETP Values Obtained during the Desorption Step
of the Ion-Exchange Process for Diﬀerent Linear Velocities




Table 3. Recovery of Cephamycin C in Fixed-Bed Column




(mL/min) total feed washing
elution
(0.1% NaCl)
CR1 2.5 85.8 43.4 30.8 11.5
CR2 5.0 92.2 38.9 36.9 16.4
CR3 7.5 88.3 32.3 37.9 18.2
Figure 3. Cephamycin C proﬁle during fraction application, washing,
and elution during solid-phase extraction on a C18 cartridge. The
fraction consisted of the puriﬁed peak of CepC obtained after ion
exchange. Washing was carried out using deionized water, and
methanol (50%) was used in elution.
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3.2. Qualitative Evaluation of CepC Puriﬁcation after
Ion Exchange on QXL Resin Followed by Solid-Phase
Extraction on a C18 Cartridge by Mass Spectrometry. As
discussed above, a partially puriﬁed peak of CepC was obtained
after the ion-exchange column process. It was not possible to
carry out a quantitative analysis of the contaminants because
chemical standards for these compounds are not commercially
available and there is no alternative methodology for
determining them. To evaluate the puriﬁcation attained,
samples of this peak and of the clariﬁed broth were analyzed
by mass spectrometry.
Prior to their injection into the mass spectrometer, the
fractions collected in the ion-exchange assays were subjected to
a desalination process using solid-phase extraction. Figure 3
shows the CepC proﬁles during the feed application, washing,
and elution steps. Four fractions were collected during elution
Figure 4. UV chromatogram at 254 nm for fractions (F) obtained during solid-phase extraction using a C18 cartridge: (A) F12, (B) F13, and (C)
F14.
Figure 5. Molecular structures of (A) cephamycin C, (B) penicillin N,
(C) deacetylcephalosporin C, and (D) deacetoxycephalosporin C.
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with 50% methanol. The chromatograms obtained at 254 nm
suggested that fractions 12 (F12) and 13 (F13) had high
degrees of purity (Figure 4A,B), as they showed a major peak
corresponding to CepC and other very small peaks
corresponding to contaminants. When compared to the other
fractions, fraction 14 (F14) (Figure 4C) was more concentrated
in CepC, but it also contained three or four other minor peaks.
F12 was then collected and injected into the LC−MS
instrument, as well as a sample of the clariﬁed broth. The
ionization was carried out in positive mode; therefore, the m/z
ratio detected for each molecule corresponded to its molecular
mass plus 1. The total-ion chromatogram of each sample was
obtained. Afterward, the base-peak chromatograms were
extracted by selecting speciﬁed ranges of m/z ratios. The m/z
ranges chosen corresponded to the molecular mass of the
protonated monitored molecule plus or minus 0.5. This narrow
range was used to avoid the detection of diﬀerent compounds
in the base-peak chromatograms.
The signals (m/z ratios) monitored in these analyses were
the signals generated by ions corresponding to a molecule of
CepC and to molecules of some compounds that could be
contaminants. The molecules investigated as possible con-
taminants consisted of some intermediates in the CepC
biosynthetic pathway, namely, deacetoxycephalosporin C (m/
z 358), deacetylcephalosporin C (m/z 374), and penicillin N
(m/z 360). Previous studies showed that the broth also
contained small amounts of these compounds.31 As these
compounds have structures that are very similar to that of
CepC (Figure 5), they could have similar aﬃnities for the ion-
exchange resin and the adsorbent used, in which case they
could not have been separated. The other compound
monitored in this analysis was the amino acid lysine (m/z
147), which is added to the culture medium in large amounts.
Figures 6 and 7 show the total-ion and base-peak
chromatograms obtained for the clariﬁed broth and for F12,
respectively. The chromatograms obtained revealed that some
of the selected compounds were present in both the clariﬁed
broth and F12. Nevertheless, when observing the base-peak
chromatograms, it is noteworthy that the ratios of the
monitored contaminants to CepC were diminished in F12
compared to the clariﬁed broth and that lysine was not detected
in F12.
The mass spectrometry methodology used to verify the
separation of CepC from the monitored contaminants did not
permit a separate evaluation of the ion-exchange process, as the
desalination step is necessary prior to injection into the LC−
MS system. Possibly, adsorption on the C18 adsorbent also
Figure 6. (A) Total-ion chromatogram (TIC) and (B−F) base-peak chromatograms of the clariﬁed broth used in the ion-exchange column process.
Base-peak chromatograms were obtained by selecting the m/z ratio for each monitored compound, as follows: (B) cephamycin C (m/z 447), (C)
penicillin N (m/z 360), (D) deacetylcephalosporin C (m/z 374), (E) deacetoxycephalosporin C (m/z 358), (F) lysine (m/z 147).
Figure 7. (A) Total-ion chromatogram (TIC) and (B−F) base-peak
chromatograms of F12 obtained during solid-phase extraction. Base-
peak chromatograms were obtained by selecting the m/z ratio for each
monitored compound, as follows: (B) cephamycin C (m/z 447), (C)
penicillin N (m/z 360), (D) deacetylcephalosporin C (m/z 374), (E)
deacetoxycephalosporin C (m/z 358), (F) lysine (m/z 147).
Industrial & Engineering Chemistry Research Article
DOI: 10.1021/ie504499z
Ind. Eng. Chem. Res. 2015, 54, 3018−3026
3024
promoted a puriﬁcation of the fractions collected in the ion-
exchange column. Therefore, the results demonstrated that the
ion-exchange process followed by a chromatographic process
on a C18 adsorbent is a suitable procedure for purifying CepC
from fermentation broth.
4. CONCLUSIONS
A ﬁxed-bed column process using the anionic resin Q
Sepharose XL was able to separate CepC from fermentation
broth. The use of ﬂow rates varying between 2.5 and 7.5 mL/
min did not inﬂuence the bed utilization or the resin uptake
capacity. The highest ﬂow rate (7.5 mL/min) provided the best
productivity values during the feed step of the process, whereas
the lowest ﬂow rate (2.5 mL/min) provided the best column
eﬃciency during desorption. A stepwise gradient for column
elution using NaCl solution was able to separate a peak
containing CepC from another peak containing other anti-
biotics. However, other compounds were also eluted together
with CepC. A subsequent chromatographic process on a C18
adsorbent decreased the concentration of contaminants in the
sample, improving the CepC puriﬁcation results. This process
was able to separate CepC from a compound with an m/z ratio
corresponding to that of lysine. Additionally, compounds with
m/z ratios corresponding to some contaminants, namely,
deacetylcephalosporin C, deacetoxycephalosporin C, and
penicillin N, also had their concentrations reduced after this
process. It was then concluded that the ion-exchange process
followed by adsorption on a C18 adsorbent is an eﬃcient
method for purifying CepC from fermentation broth. This
result is of great interest taking into account the current
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